ARTICLE | Clinical News
ALX1-11 recombinant human parathyroid hormone: Will start in April a 12-month Phase II trial at three dose levels and placebo, to test ALX1-11's efficacy in cha
March 20, 1995 8:00 AM UTC
Allelix Biopharmaceuticals Inc. (AXB), Toronto Product: ALX1-11 recombinant human parathyroid hormone Indication: Osteoporosis Status: Will start in April a 12-month Phase II trial at three dose lev...